Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Acute Interstitial Nephritis in a Patient with Non-Small Cell Lung Cancer under Immunotherapy with Nivolumab.

Georgianos PI, Vaios V, Leontaridou E, Karayannopoulou G, Koletsa T, Sioulis A, Balaskas EV, Zebekakis PE.

Case Rep Nephrol. 2019 Jan 15;2019:3614980. doi: 10.1155/2019/3614980. eCollection 2019.

PMID:
30775040
2.

Low-dose combination therapy to control sustained ambulatory hypertension-Basic principles and future directions.

Georgianos PI, Liakopoulos V, Zebekakis PE.

J Clin Hypertens (Greenwich). 2019 Feb;21(2):249-251. doi: 10.1111/jch.13468. Epub 2018 Dec 24. No abstract available.

3.

Hypertension in chronic kidney disease: Nephrology Dialysis Transplantation notable 2017 advances.

Georgianos PI, Agarwal R.

Nephrol Dial Transplant. 2019 Jan 1;34(1):1-4. doi: 10.1093/ndt/gfy348. No abstract available.

PMID:
30541107
4.

Accuracy of a Newly-Introduced Oscillometric Device for the Estimation of Arterial Stiffness Indices in Patients on Peritoneal Dialysis: A Preliminary Validation Study.

Vaios V, Georgianos PI, Pikilidou MI, Eleftheriadis T, Zarogiannis S, Papagianni A, Zebekakis PE, Liakopoulos V.

Adv Perit Dial. 2018 Nov;34(2018):24-31.

PMID:
30480533
5.

Icodextrin-associated generalized exfoliative skin rash in a CAPD patient: a case-report.

Liakopoulos V, Georgianos PI, Demirtzi P, Vaios V, Kalathas T, Zebekakis PE.

BMC Nephrol. 2018 Oct 25;19(1):293. doi: 10.1186/s12882-018-1071-6.

6.

Meet the Twins: Intradialytic and Interdialytic Hypertension.

Georgianos PI, Agarwal R.

Am J Nephrol. 2018;48(4):292-294. doi: 10.1159/000493990. Epub 2018 Oct 22. No abstract available.

7.

Assessment and Management of Hypertension among Patients on Peritoneal Dialysis.

Vaios V, Georgianos PI, Liakopoulos V, Agarwal R.

Clin J Am Soc Nephrol. 2018 Oct 19. pii: CJN.07480618. doi: 10.2215/CJN.07480618. [Epub ahead of print] Review.

PMID:
30341090
8.

General obesity, abdominal adiposity, and the risk of incident hypertension-From anthropometry to modern imaging techniques.

Georgianos PI, Zebekakis PE.

J Clin Hypertens (Greenwich). 2018 Oct;20(10):1427-1429. doi: 10.1111/jch.13377. No abstract available.

9.

Antihypertensive therapy in acute ischemic stroke: where do we stand?

Georgianou E, Georgianos PI, Petidis K, Athyros VG, Sarafidis PA, Karagiannis A.

J Hum Hypertens. 2018 Dec;32(12):799-807. doi: 10.1038/s41371-018-0105-7. Epub 2018 Sep 19.

PMID:
30232398
10.

Blood pressure control in conventional hemodialysis.

Georgianos PI, Agarwal R.

Semin Dial. 2018 Nov;31(6):557-562. doi: 10.1111/sdi.12741. Epub 2018 Aug 6.

PMID:
30084190
11.

SGLT-2 inhibitors in diabetic kidney disease: what lies behind their renoprotective properties?

Georgianos PI, Divani M, Eleftheriadis T, Mertens PR, Liakopoulos V.

Curr Med Chem. 2018 May 23. doi: 10.2174/0929867325666180524114033. [Epub ahead of print]

PMID:
29792136
12.

Arterial stiffness in end-stage renal disease-pathogenesis, clinical epidemiology, and therapeutic potentials.

Georgianos PI, Pikilidou MI, Liakopoulos V, Balaskas EV, Zebekakis PE.

Hypertens Res. 2018 May;41(5):309-319. doi: 10.1038/s41440-018-0025-5. Epub 2018 Mar 12. Review.

PMID:
29531291
13.

Home blood pressure-guided antihypertensive therapy in chronic kidney disease: more data are needed.

Georgianos PI, Champidou E, Liakopoulos V, Balaskas EV, Zebekakis PE.

J Am Soc Hypertens. 2018 Apr;12(4):242-247. doi: 10.1016/j.jash.2018.02.002. Epub 2018 Feb 10.

PMID:
29459219
14.

Revisiting RAAS blockade in CKD with newer potassium-binding drugs.

Georgianos PI, Agarwal R.

Kidney Int. 2018 Feb;93(2):325-334. doi: 10.1016/j.kint.2017.08.038. Epub 2017 Dec 21. Review.

15.

Comparison of Glycemic Markers in Chronic Hemodialysis Using Continuous Glucose Monitoring.

Divani M, Georgianos PI, Didangelos T, Iliadis F, Makedou A, Hatzitolios A, Liakopoulos V, Grekas DM.

Am J Nephrol. 2018;47(1):21-29. doi: 10.1159/000485843. Epub 2017 Dec 22.

PMID:
29275415
16.

Blood pressure and target-organ damage in hemodialysis: but which blood pressure?

Georgianos PI, Vaios V, Liakopoulos V, Zebekakis PE.

J Hypertens. 2017 Dec;35(12):2552-2553. doi: 10.1097/HJH.0000000000001553. No abstract available.

PMID:
29095236
17.

Evaluation of the tolerability and efficacy of sodium polystyrene sulfonate for long-term management of hyperkalemia in patients with chronic kidney disease.

Georgianos PI, Liampas I, Kyriakou A, Vaios V, Raptis V, Savvidis N, Sioulis A, Liakopoulos V, Balaskas EV, Zebekakis PE.

Int Urol Nephrol. 2017 Dec;49(12):2217-2221. doi: 10.1007/s11255-017-1717-5. Epub 2017 Oct 11.

PMID:
29027620
18.

Blood pressure in hemodialysis: targets?

Georgianos PI, Agarwal R.

Curr Opin Nephrol Hypertens. 2017 Nov;26(6):523-529. doi: 10.1097/MNH.0000000000000359. Review.

19.

Endothelin A receptor antagonists in diabetic kidney disease.

Georgianos PI, Agarwal R.

Curr Opin Nephrol Hypertens. 2017 Sep;26(5):338-344. doi: 10.1097/MNH.0000000000000342. Review.

PMID:
28520568
20.

Mineralocorticoid Antagonists in ESRD: An Overview of Clinical Trial Evidence.

Georgianos PI, Vaios V, Eleftheriadis T, Zebekakis P, Liakopoulos V.

Curr Vasc Pharmacol. 2017;15(6):599-606. doi: 10.2174/1570161115666170201113817. Review.

PMID:
28155610
21.

Exploring the association of arterial stiffness with estimated glomerular filtration rate: another chicken-egg paradigm?

Georgianos PI, Morfesis P, Zebekakis PE.

J Hypertens. 2017 Mar;35(3):650-651. doi: 10.1097/HJH.0000000000001238. No abstract available.

PMID:
28121844
22.

Pharmacotherapy of Hypertension in Chronic Dialysis Patients.

Georgianos PI, Agarwal R.

Clin J Am Soc Nephrol. 2016 Nov 7;11(11):2062-2075. Epub 2016 Oct 24. Review.

23.

Echocardiographic Parameters During Long and Short Interdialytic Intervals in Hemodialysis Patients.

Tsilonis K, Sarafidis PA, Kamperidis V, Loutradis C, Georgianos PI, Imprialos K, Ziakas A, Sianos G, Nikolaidis P, Lasaridis AN, Karvounis H.

Am J Kidney Dis. 2016 Nov;68(5):772-781. doi: 10.1053/j.ajkd.2016.06.017. Epub 2016 Aug 18.

PMID:
27545351
24.

Blood Pressure and Mortality in Long-Term Hemodialysis-Time to Move Forward.

Georgianos PI, Agarwal R.

Am J Hypertens. 2017 Mar 1;30(3):211-222. doi: 10.1093/ajh/hpw114. Review.

25.

Epidemiology, diagnosis and management of hypertension among patients on chronic dialysis.

Georgianos PI, Agarwal R.

Nat Rev Nephrol. 2016 Oct;12(10):636-47. doi: 10.1038/nrneph.2016.129. Epub 2016 Aug 30. Review.

PMID:
27573731
26.

Con: Nutritional vitamin D replacement in chronic kidney disease and end-stage renal disease.

Agarwal R, Georgianos PI.

Nephrol Dial Transplant. 2016 May;31(5):706-13. doi: 10.1093/ndt/gfw080.

27.

Opponent's comments.

Agarwal R, Georgianos PI.

Nephrol Dial Transplant. 2016 May;31(5):705. doi: 10.1093/ndt/gfw082a. No abstract available.

PMID:
27190391
28.

Treating Hypertension in Diabetic Patients With Advanced Chronic Kidney Disease: What Should We Have in Mind?

Georgianos PI, Balaskas EV, Zebekakis PE.

J Clin Hypertens (Greenwich). 2016 Oct;18(10):1076. doi: 10.1111/jch.12836. Epub 2016 May 11. No abstract available.

29.

A comparison study of brachial blood pressure recorded with Spacelabs 90217A and Mobil-O-Graph NG devices under static and ambulatory conditions.

Sarafidis PA, Lazaridis AA, Imprialos KP, Georgianos PI, Avranas KA, Protogerou AD, Doumas MN, Athyros VG, Karagiannis AI.

J Hum Hypertens. 2016 Dec;30(12):742-749. doi: 10.1038/jhh.2016.11. Epub 2016 Mar 3.

PMID:
26935286
30.

Hemodialysis patients with intradialytic rise in blood pressure display higher baseline aortic stiffness and negligible drop in augmentation index with dialysis.

Georgianos PI, Mpoutsiouki F, Sabani E, Stamatiadis DN, Liakopoulos V, Balaskas EV, Zebekakis PE, Sarafidis PA.

Int Urol Nephrol. 2016 Apr;48(4):601-8. doi: 10.1007/s11255-015-1205-8. Epub 2016 Jan 14.

PMID:
26769025
31.

New Potassium Binders: A Call to Test Their Efficacy and Safety in Dialysis Patients.

Georgianos PI, Sarafidis PA.

Am J Kidney Dis. 2016 Jan;67(1):165-6. doi: 10.1053/j.ajkd.2015.09.029. No abstract available.

PMID:
26708196
32.

Mineralocorticoid Receptor Antagonism for Cardiovascular Protection in End-Stage Renal Disease: New Data But the Controversy Continues.

Georgianos PI, Sarafidis PA, Liakopoulos V, Balaskas EV, Zebekakis PE.

J Clin Hypertens (Greenwich). 2016 Mar;18(3):197-9. doi: 10.1111/jch.12718. Epub 2015 Oct 12. No abstract available.

33.

Relative Importance of Aortic Stiffness and Volume as Predictors of Treatment-Induced Improvement in Left Ventricular Mass Index in Dialysis.

Georgianos PI, Agarwal R.

PLoS One. 2015 Sep 10;10(9):e0135457. doi: 10.1371/journal.pone.0135457. eCollection 2015.

34.

Advances in treatment of hyperkalemia in chronic kidney disease.

Sarafidis PA, Georgianos PI, Bakris GL.

Expert Opin Pharmacother. 2015;16(14):2205-15. doi: 10.1517/14656566.2015.1083977. Epub 2015 Sep 2. Review.

PMID:
26330193
35.

Intradialysis Hypertension in End-Stage Renal Disease Patients: Clinical Epidemiology, Pathogenesis, and Treatment.

Georgianos PI, Sarafidis PA, Zoccali C.

Hypertension. 2015 Sep;66(3):456-63. doi: 10.1161/HYPERTENSIONAHA.115.05858. Epub 2015 Jul 6. Review. No abstract available.

PMID:
26150436
36.

Adverse effects of conventional thrice-weekly hemodialysis: is it time to avoid 3-day interdialytic intervals?

Georgianos PI, Sarafidis PA, Sinha AD, Agarwal R.

Am J Nephrol. 2015;41(4-5):400-8. doi: 10.1159/000435842. Epub 2015 Jun 27. Review.

37.

Ambulatory aortic blood pressure, wave reflections and pulse wave velocity are elevated during the third in comparison to the second interdialytic day of the long interval in chronic haemodialysis patients.

Koutroumbas G, Georgianos PI, Sarafidis PA, Protogerou A, Karpetas A, Vakianis P, Raptis V, Liakopoulos V, Panagoutsos S, Syrganis C, Passadakis P.

Nephrol Dial Transplant. 2015 Dec;30(12):2046-53. doi: 10.1093/ndt/gfv090. Epub 2015 Apr 28.

38.

Aortic Stiffness, Ambulatory Blood Pressure, and Predictors of Response to Antihypertensive Therapy in Hemodialysis.

Georgianos PI, Agarwal R.

Am J Kidney Dis. 2015 Aug;66(2):305-12. doi: 10.1053/j.ajkd.2015.01.018. Epub 2015 Mar 25.

PMID:
25818679
39.

Effect of lisinopril and atenolol on aortic stiffness in patients on hemodialysis.

Georgianos PI, Agarwal R.

Clin J Am Soc Nephrol. 2015 Apr 7;10(4):639-45. doi: 10.2215/CJN.09981014. Epub 2015 Mar 17.

40.

Arterial Stiffness: A Novel Risk Factor for Kidney Injury Progression?

Georgianos PI, Sarafidis PA, Liakopoulos V.

Am J Hypertens. 2015 Aug;28(8):958-65. doi: 10.1093/ajh/hpv004. Epub 2015 Feb 15. Review.

PMID:
25687879
41.

Ambulatory recording of wave reflections and arterial stiffness during intra- and interdialytic periods in patients treated with dialysis.

Karpetas A, Sarafidis PA, Georgianos PI, Protogerou A, Vakianis P, Koutroumpas G, Raptis V, Stamatiadis DN, Syrganis C, Liakopoulos V, Efstratiadis G, Lasaridis AN.

Clin J Am Soc Nephrol. 2015 Apr 7;10(4):630-8. doi: 10.2215/CJN.08180814. Epub 2015 Jan 29.

42.

Opponent's comment.

Georgianos PI, Sarafidis PA.

Nephrol Dial Transplant. 2015 Jan;30(1):27-8. doi: 10.1093/ndt/gfu382a. No abstract available.

PMID:
25568224
43.

Pro: Should we move to more frequent haemodialysis schedules?

Georgianos PI, Sarafidis PA.

Nephrol Dial Transplant. 2015 Jan;30(1):18-22. doi: 10.1093/ndt/gfu381. Epub 2014 Dec 23.

PMID:
25538158
44.

Comparative epidemiology of resistant hypertension in chronic kidney disease and the general hypertensive population.

Sarafidis PA, Georgianos PI, Zebekakis PE.

Semin Nephrol. 2014;34(5):483-91. doi: 10.1016/j.semnephrol.2014.08.001. Review.

PMID:
25416656
45.

Evaluation of a novel brachial cuff-based oscillometric method for estimating central systolic pressure in hemodialysis patients.

Sarafidis PA, Georgianos PI, Karpetas A, Bikos A, Korelidou L, Tersi M, Divanis D, Tzanis G, Mavromatidis K, Liakopoulos V, Zebekakis PE, Lasaridis A, Protogerou AD.

Am J Nephrol. 2014;40(3):242-50. doi: 10.1159/000367791. Epub 2014 Oct 11.

PMID:
25322847
46.

Renin-angiotensin system blockade and exercise-induced increase in aortic stiffness.

Georgianos PI, Sarafidis PA, Zebekakis PE.

J Clin Hypertens (Greenwich). 2014 Jul;16(7):475-6. doi: 10.1111/jch.12339. Epub 2014 May 19. No abstract available.

47.

Elevated asymmetric dimethylarginine is associated with oxidant stress aggravation in patients with early stage autosomal dominant polycystic kidney disease.

Raptis V, Georgianos PI, Sarafidis PA, Sioulis A, Makedou K, Makedou A, Grekas DM, Kapoulas S.

Kidney Blood Press Res. 2013;38(1):72-82. doi: 10.1159/000355756. Epub 2014 Feb 18.

48.

Hemodiafiltration does not have additional benefits over hemodialysis on arterial stiffness, wave reflections and central aortic pressures.

Georgianos PI, Sarafidis PA, Karpetas A, Kosmidis D, Sioulis A, Liakopoulos V, Stamatiadis DN, Papagianni A, Zebekakis PE, Nikolaidis P, Lasaridis AN.

Blood Purif. 2014;37(1):18-26. doi: 10.1159/000355945. Epub 2014 Jan 28.

PMID:
24481249
49.

Arterial stiffness: a novel cardiovascular risk factor in kidney disease patients.

Georgianos PI, Sarafidis PA, Lasaridis AN.

Curr Vasc Pharmacol. 2015;13(2):229-38. Review.

PMID:
24007427
50.

Diverse effects of interdialytic intervals on central wave augmentation in haemodialysis patients.

Georgianos PI, Sarafidis PA, Haidich AB, Karpetas A, Stamatiadis D, Nikolaidis P, Lasaridis AN.

Nephrol Dial Transplant. 2013 Aug;28(8):2160-9. doi: 10.1093/ndt/gft085. Epub 2013 May 3.

PMID:
23645477

Supplemental Content

Loading ...
Support Center